| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087637 Substituted indoles which are PARP inhibitors |
| 08/08/2006 | US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation |
| 08/08/2006 | US7087632 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087628 Heteroaryl and heterocyclic nitrogen ring containing hydrazide compounds useful for treating neurodegenerative disorderes |
| 08/08/2006 | US7087626 TGF-beta signal transduction inhibitors |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087608 Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/08/2006 | US7087606 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087601 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/08/2006 | US7087594 Alkyl ether derivatives or salts thereof |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087586 Oligonucleotide compositions and their use to induce differentiation of cells |
| 08/08/2006 | US7087581 Regeneration of sensitive cells with cell proliferative agents; cyclin-dependent kinase inhibitor; administering antibody |
| 08/08/2006 | US7087579 Human sodium glucose co-transporter 2 (SGLT2) inhibitors; hypoglycemic agents, antidiabetic agents; obesity; prodrugs |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087413 Hyaluronan synthase gene and uses thereof |
| 08/08/2006 | US7087405 Anticancer agents; rheumatic diseases; genetic engineered plasmid |
| 08/08/2006 | US7087399 Purification; analyzing; drug screening; Alzheimer's diseases; central nervous system disorders |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087247 Polyesters, method for producing same, and depot medicaments produced from these polyesters |
| 08/08/2006 | US7087233 Preventing fetal damage by administering germination activated Ganoderma lucidum spore powder to a pregnant mammal |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | CA2394902C Effervescent histamine h2 antagonist composition |
| 08/08/2006 | CA2358938C Methods for assessing, improving, or maintaining urogenital health in postmenopausal women |
| 08/08/2006 | CA2356985C 5ht1 antagonists for antidepressant therapy |
| 08/08/2006 | CA2282183C Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 08/08/2006 | CA2240571C The use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/08/2006 | CA2097063C Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
| 08/03/2006 | WO2006081251A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/03/2006 | WO2006080581A1 Agent for control of degranulation reaction and cytokine production |
| 08/03/2006 | WO2006080574A1 1,3-dihydro-2h-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 08/03/2006 | WO2006080524A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 08/03/2006 | WO2006080519A1 Diamine derivative |
| 08/03/2006 | WO2006080463A1 Therapeutic agent for cancer and recurrence preventive each containing vitamin k hydroquinone derivative |
| 08/03/2006 | WO2006080450A1 Igf-1r inhibitor |
| 08/03/2006 | WO2006080421A1 Spiroketal derivative and use thereof as diabetic medicine |
| 08/03/2006 | WO2006080407A1 Ppar-activating compound |
| 08/03/2006 | WO2006080340A1 Concomitant use of hepatitis c virus-origin peptide with interferon |
| 08/03/2006 | WO2006080323A1 Six-membered heterocyclic compound and the use thereof |
| 08/03/2006 | WO2006080312A1 Method for producing adsorptive porous body |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006080118A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | WO2006079796A1 Treatment for mucositis |
| 08/03/2006 | WO2006000339A3 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 08/03/2006 | WO2003014318A3 Methods for treating diabetes and other blood sugar disorders |
| 08/03/2006 | US20060173076 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173072 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound |
| 08/03/2006 | US20060173059 Agent for preventing or treating portal hypertension |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173045 Preventative or remedy for grinding |
| 08/03/2006 | US20060173039 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173031 Therapeutic agent for schizophrenia |
| 08/03/2006 | US20060173030 Antitumoral analogs of lamellarins |
| 08/03/2006 | US20060173010 Modulators of TNF-alpha signaling |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172960 cellular senescence and immortalization; administering a telemerase inhibitor; reduced loss of telomere length; antiproliferative agents |
| 08/03/2006 | US20060172955 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060172947 Physiologically active peptides and drugs containing the same |
| 08/03/2006 | US20060172946 Having serine protease inhibitory activity |
| 08/03/2006 | US20060172932 Novel erythropoietin receptor agonists |
| 08/03/2006 | US20060172930 Apoptosis-inducing gene and utilization of the same |
| 08/03/2006 | US20060172929 Use of natriuretic peptides for the treatment of stature disorders related to the shox gene |
| 08/03/2006 | US20060172391 BMP-11 compositions |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172297 Enhancers specific to motor nerve cells/sensory nerve cells |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/03/2006 | CA2596527A1 Igf-1r inhibitors |
| 08/03/2006 | CA2596371A1 Agent for control degranulation reaction and cytokine production |
| 08/03/2006 | CA2596237A1 Diamine derivative |
| 08/03/2006 | CA2596235A1 Spiroketal derivatives and use thereof as diabetic medicine |
| 08/03/2006 | CA2596230A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | CA2595711A1 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 08/02/2006 | EP1686181A2 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 08/02/2006 | EP1686136A1 Novel glycoprotein and medicinal composition containing the same |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1686119A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/02/2006 | EP1686113A1 Inhibitors of aspartyl protease |
| 08/02/2006 | EP1685846A1 Antitumor agent |
| 08/02/2006 | EP1685842A2 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 08/02/2006 | EP1685840A2 Use of tetrahydrofolates for modulating the homocysteine level |
| 08/02/2006 | EP1685839A1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist |
| 08/02/2006 | EP1685833A1 Remedy for diabetes |
| 08/02/2006 | EP1685832A1 Nerve regeneration promoters |
| 08/02/2006 | EP1685822A1 Glucose absorption inhibitor and process for producing the same |